TGFB1 and membranous glomerulonephritis: Previous study in our laboratory had demonstrated that skimmin has renal protective effect in experimental diabetic nephropathy by inhibiting the activation of TGFβ1-smad signaling [18] and membranous nephropathy by reducing low-grade inflammation, inhibiting cytokines production and infiltration of lymphocytes [19].